More Articles
A team of cardiologists and surgeons at Hackensack University Medical Center in New Jersey believe they have made history by…
Medical researchers have stayed busy in recent years working to develop new interventional heart failure treatments that offer more relief than…
The U.S. Food and Drug Administration (FDA) has approved mavacamten, sold by Bristol Myers Squibb (BMS) under the name Camzyos, for the treatment of adult patients…
The U.S. Food and Drug Administration (FDA)…
Hospitalizations for heart failure (HF) are on the rise among young adults, according to a new study published in JACC: Heart Failure.[1]…
The Penn State College of Medicine has received more than $3 million from the National Heart, Lung and Blood Institute to develop an implantable, wireless…
The U.S. Food and Drug Administration (FDA) has announced…
Interventional cardiologists at Cleveland Clinic have successfully completed the first implantation in North America of the…
Infertility, which affects one in five U.S. women, was found to be associated with a 16% increase in heart failure risk in a new study published by the Journal of the American College of…
Here are links to all the American College of Cardiology (ACC) late-breaking clinical studies presented at the 2022 ACC Annual Scientific Session. ACC.22 took place April 2-4, 2022, in Washington, D.C.
These latest…
More than 25 months after COVID-19 was officially categorized as a pandemic by the World Health Organization, researchers are still working to learn as much as…
Percutaneous radiofrequency ablation–based interatrial shunting could be a safe and effective treatment option for patients with heart failure with preserved…
Citing significant advances in genomic technology over the past decade, an …
ACC.22, the American College of Cardiology’s 71st Annual Scientific Session & Expo, is officially underway in Washington, D.C.
The conference’s second full day, April 3, included a wide variety…
Congress has opened an investigation into how the FDA handled the 2021 recall of Medtronic’s HeartWare Ventricular Assist Device (HVAD) system.
The recall,…
Can spirituality improve quality of life for heart failure patients? A literature review published today in JACC: Heart Failure suggests that…
Researchers have developed deep learning models capable of identifying right ventricular (RV) and left ventricular (LV) dysfunction from electrocardiogram (ECG) findings…
Patients who have already had myocarditis may not face a higher risk of developing that same condition again after receiving a COVID-19…
Percutaneous coronary intervention (PCI) can improve the odds of survival for certain ischemic heart failure (HF) patients with moderate-to-severe functional mitral regurgitation (FMR), according to new findings published in the …